Is Turn Therapeutics Inc. Common Stock profitable?

Turn Therapeutics Inc. Common Stock is not currently profitable: it reported a net loss of $3.5M over the trailing twelve months.

What is Turn Therapeutics Inc. Common Stock's earnings per share?

Turn Therapeutics Inc. Common Stock's diluted EPS over the trailing twelve months is $-0.13.

Where does Turn Therapeutics Inc. Common Stock's income statement data come from?

Every line is extracted from Turn Therapeutics Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Turn Therapeutics Inc. Common Stock TTRX Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Research and development	$109.43K+1,082%	$34.93K+258%	$158.7K+3.5%	$62.68K—	$9.26K—
General and administrative	$1.14M+203%	$2.16M+576%	$1.75M+238%	$1.3M—	$375.74K—
Other operating expenses	$1.25M+224%	$2.19M+567%	$1.91M+184%	$1.37M—	$385K—
Total operating expenses	$1.25M+224%	$2.19M+567%	$1.91M+184%	$1.37M—	$385K—
Operating income	-$1.25M-224%	-$2.19M-567%	-$1.91M-184%	-$1.37M—	-$385K—
Interest income	$49.68K+862%	$14.18K+143%	$5.11K-22.0%	$5.13K—	$5.17K—
Other income (expense), net	$275.17K+387%	$2.47M+42,334%	$9.37K+43.1%	$126.11K—	$56.45K—
Net investment gains (losses)	$697.56K+8.4%	$643.74K—	$643.74K—	$643.74K—	$643.74K—
Net income	-$970.97K-196%	——	-$1.9M-186%	——	-$328.55K—
Diluted earnings per share	-$0.03-200%	——	-$0.07-133%	——	-$0.01—
Basic earnings per share	-$0.03-200%	——	-$0.07-133%	——	-$0.01—
Weighted-average shares, diluted	29.5M+9.3%	27.7M+4.0%	28M+5.0%	——	27M—
Weighted-average shares, basic	29.5M+9.3%	27.7M+4.0%	28M+5.0%	——	27M—
Gain From Change In Fair Value Of Forward Contract Liability	——	-$95.11K—	-$95.11K—	-$95.11K—	-$95.11K—
Other income, net (Note 6)	$5.58K-89.1%	——	$4.26K—	——	$51.29K—
EBIT	-$1.25M-224%	-$2.19M-567%	-$1.91M-184%	-$1.37M—	-$385K—
EBITDA	——	-$2.18M-588%	-$1.9M-187%	-$1.35M—	-$371.81K—
EBIT	-$1.25M-224%	-$2.19M-567%	-$1.91M-184%	-$1.37M—	-$385K—

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Is Turn Therapeutics Inc. Common Stock profitable?: Turn Therapeutics Inc. Common Stock is not currently profitable: it reported a net loss of $3.5M over the trailing twelve months.
What is Turn Therapeutics Inc. Common Stock's earnings per share?: Turn Therapeutics Inc. Common Stock's diluted EPS over the trailing twelve months is $-0.13.
Where does Turn Therapeutics Inc. Common Stock's income statement data come from?: Every line is extracted from Turn Therapeutics Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.